EI
MDT icon

Ethic Inc’s Medtronic MDT Stock Holding History

Ethic Inc’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.4M Buy
158,467
+12,713
+9% +$1.03M 0.15% 128
2026
Q1 		$12.6M Buy
145,754
+2,705
+2% +$259K 0.2% 100
2025
Q4 		$13.7M Buy
143,049
+7,637
+6% +$742K 0.21% 87
2025
Q3 		$12.9M Sell
135,412
-11,006
-8% -$1.01M 0.21% 90
2025
Q2 		$12.6M Buy
146,418
+6,725
+5% +$570K 0.23% 84
2025
Q1 		$12.4M Buy
139,693
+36,520
+35% +$3.27M 0.25% 76
2024
Q4 		$8.24M Sell
103,173
-37,014
-26% -$3.2M 0.17% 127
2024
Q3 		$12.2M Buy
140,187
+91,800
+190% +$7.72M 0.31% 62
2024
Q2 		$3.81M Sell
48,387
-91,800
-65% -$7.53M 0.09% 243
2024
Q1 		$12.2M Buy
140,187
+13,825
+11% +$1.18M 0.31% 62
2023
Q4 		$10.4M Buy
126,362
+4,617
+4% +$352K 0.31% 58
2023
Q3 		$9.54M Buy
121,745
+5,218
+4% +$437K 0.33% 51
2023
Q2 		$10.3M Buy
116,527
+716
+0.6% +$61.6K 0.38% 40
2023
Q1 		$9.34M Buy
115,811
+47,012
+68% +$3.83M 0.38% 42
2022
Q4 		$5.35M Buy
68,799
+19,744
+40% +$1.6M 0.29% 80
2022
Q3 		$3.96M Buy
49,055
+15,898
+48% +$1.43M 0.27% 93
2022
Q2 		$2.98M Buy
33,157
+3,811
+13% +$386K 0.21% 122
2022
Q1 		$3.26M Buy
29,346
+7,421
+34% +$784K 0.22% 111
2021
Q4 		$2.27M Buy
21,925
+419
+2% +$48.5K 0.17% 143
2021
Q3 		$2.7M Buy
21,506
+2,627
+14% +$340K 0.28% 84
2021
Q2 		$2.34M Buy
18,879
+3,258
+21% +$409K 0.28% 80
2021
Q1 		$1.84M Buy
15,621
+1,655
+12% +$194K 0.33% 68
2020
Q4 		$1.64M Buy
13,966
+2,220
+19% +$244K 0.43% 43
2020
Q3 		$1.22M Sell
11,746
-2,599
-18% -$261K 0.47% 39
2020
Q2 		$1.31M Buy
14,345
+4,905
+52% +$470K 0.75% 27
2020
Q1 		$851K Buy
9,440
+2,038
+28% +$217K 0.71% 33
2019
Q4 		$840K Buy
+7,402
New +$812K 0.62% 39

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Ethic Inc's MDT Position: Q2 2026 in Review

Ethic Inc increased its Medtronic (MDT) stake by 8.7% in Q2 2026, buying an estimated $1.03M and bringing the position to 158,467 shares worth $12.4M. The position accounts for 0.15% of the portfolio, ranked #128.

Ethic Inc first reported a position in MDT in Q4 2019 and has held it in 27 quarters since. The position peaked at $13.7M in Q4 2025. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Ethic Inc held 158,467 shares of Medtronic worth $12.4M as of Q2 2026.
  • Ethic Inc bought 12,713 Medtronic shares in Q2 2026, an estimated $1.03M.
  • Medtronic made up 0.15% of Ethic Inc's portfolio in Q2 2026, its #128 holding.
  • Ethic Inc first reported a position in Medtronic in Q4 2019 and has held it in 27 quarters since.
  • Ethic Inc's Medtronic position peaked at $13.7M in Q4 2025.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.